EXEL
Exelixis, Inc.NASDAQHealthcare$43.88-0.36%ClosedMarket Cap: $11.76B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
12
Sales
33
Buy/Sell Ratio
0.36
Total Bought
$0.00
Total Sold
$14.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Mar 02 | Aftab Dana | officer: EVP, Research and Development | Sell | 52,018 | $0.00 | 668,124 |
| Mon Mar 02 | Senner Christopher J. | officer: EVP and CFO | Sell | 52,018 | $0.00 | 1,028,110 |
| Mon Mar 02 | Hefti Brenda | officer: SVP and General Counsel | Sell | 23,119 | $0.00 | 119,631 |
| Mon Mar 02 | Haley Patrick J. | officer: EVP, Commercial | Sell | 40,459 | $0.00 | 422,367 |
| Mon Mar 02 | MORRISSEY MICHAEL | director, officer: President and CEO | Sell | 100,278 | $0.00 | 1,989,956 |
| Mon Mar 02 | MORRISSEY MICHAEL | director, officer: President and CEO | Sell | 160,437 | $0.00 | 1,614,552 |
| Thu Feb 26 | Aftab Dana | officer: EVP, Research and Development | Sell | 47,918 | $44.50 | 616,106 |
| Mon Feb 23 | Aftab Dana | officer: EVP, Research and Development | Sell | 29,873 | $44.35 | 664,024 |
| Fri Feb 20 | WYSZOMIERSKI JACK L | director | Sell | 20,634 | $19.77 | 379,516 |
| Fri Feb 20 | WYSZOMIERSKI JACK L | director | Sell | 99,574 | $44.01 | 279,942 |